Mechanisms of transforming growth factor β induced cell cycle arrest in palate development

Journal of Cellular Physiology

Volumn 226, Issue 5, 2011, Pages 1415-1424

  Iordanskaia, Tatiana ^a   Nawshad, Ali ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; SMAD BINDING ELEMENT; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; CELL CYCLE ARREST; EPITHELIAL MESENCHYMAL TRANSITION; GENE; GENE EXPRESSION; MOUSE; NONHUMAN; P15INK4B GENE; PALATE; PRIORITY JOURNAL; PROMOTER REGION; SITE DIRECTED MUTAGENESIS;

ANIMALS; APOPTOSIS; BASE SEQUENCE; BINDING SITES; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; CYCLIN-DEPENDENT KINASE INHIBITOR P15; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; PALATE; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS; SMAD4 PROTEIN; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3;

EID: 79951788860     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22477     Document Type: Article

References (42)

1. Ahmed S, Liu CC, Nawshad A. 2007. Mechanisms of palatal epithelial seam disintegration by transforming growth factor (TGF) beta3. Dev Biol 309: 193-207.
2. Amanullah A, Hoffman B, Liebermann DA. 2000. Deregulated E2F-1 blocks terminal differentiation and loss of leukemogenicity of M1 myeloblastic leukemia cells without abrogating induction of p15(INK4B) and p16(INK4A). Blood 96: 475-482.
3. Bhowmick NA, Ghiassi M, Aakre M, Brown K, Singh V, Moses HL. 2003. TGF-beta-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest. Proc Natl Acad Sci U S A 100: 15548-15553.
4. Bissell DM. 2001. Chronic liver injury, TGF-beta, and cancer. Exp Mol Med 33: 179-190.
5. Bissell DM, Roulot D, George J. 2001. Transforming growth factor beta and the liver. Hepatology 34: 859-867.
6. Caja L, Ortiz C, Bertran E, Murillo MM, Miro-Obradors MJ, Palacios E, Fabregat I. 2007. Differential intracellular signalling induced by TGF-beta in rat adult hepatocytes and hepatoma cells: implications in liver carcinogenesis. Cell Signal 19: 683-694.
7. Derynck R, Akhurst RJ, Balmain A. 2001. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 29: 117-129.
8. Ferguson MW. 1988. Palate development. Development 103: 41-60.
9. Gomis RR, Alarcon C, Nadal C, Van Poznak C, Massague J. 2006. C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 10: 203-214.
10. Guo P, Zhao KW, Dong XY, Sun X, Dong JT., 2009. Acetylation of KLF5 alters the assembly of p15 transcription factors in transforming growth factor-beta-mediated induction in epithelial cells. J Biol Chem 284: 18184-18193.
11. Hannon GJ, Beach D. 1994. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371: 257-261.
12. Haviernik P, Schmidt M, Hu X, Wolff L. 2003. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc. Oncogene 22: 1600-1610.
13. Heldin CH, Landstrom M, Moustakas A. 2009. Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 21: 166-176.
14. Ho J, de Guise C, Kim C, Lemay S, Wang XF, Lebrun JJ. 2004. Activin induces hepatocyte cell growth arrest through induction of the cyclin-dependent kinase inhibitor p15INK4B and Sp1. Cell Signal 16: 693-701.
15. Martinez-Alvarez C, Blanco MJ, Perez R, Rabadan MA, Aparicio M, Resel E, Martinez T, Nieto MA. 2004. Snail family members and cell survival in physiological and pathological cleft palates. Dev Biol 265: 207-218.
16. Martinez-Alvarez C, Tudela C, Perez-Miguelsanz J, O'Kane S, Puerta J, Ferguson MW. 2000. Medial edge epithelial cell fate during palatal fusion. Dev Biol 220: 343-357.
17. Massague J. 1998. TGF-beta signal transduction. Annu Rev Biochem 67: 753-791.
18. Massague J, Wotton D. 2000. Transcriptional control by the TGF-beta/Smad signaling system. Embo J 19: 1745-1754.
19. Moses HL, Yang EY, Pietenpol JA. 1990. TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63: 245-247.
20. Mu Z, Yang Z, Yu D, Zhao Z, Munger JS. 2008. TGFbeta1 and TGFbeta3 are partially redundant effectors in brain vascular morphogenesis. Mech Dev 125: 508-516.
21. Murray JC, Schutte BC. 2004. Cleft palate: players, pathways, and pursuits. J Clin Invest 113: 1676-1678.
22. Nawshad A. 2008. Palatal seam disintegration: to die or not to die? that is no longer the question. Dev Dyn 237: 2643-2656.
23. Nawshad A, Hay ED. 2003. TGFbeta3 signaling activates transcription of the LEF1 gene to induce epithelial mesenchymal transformation during mouse palate development. J Cell Biol 163: 1291-1301.
24. Nawshad A, LaGamba D, Hay ED. 2004. Transforming growth factor beta (TGFbeta) signalling in palatal growth, apoptosis and epithelial mesenchymal transformation (EMT). Arch Oral Biol 49: 675-689.
25. Nawshad A, Medici D, Liu CC, Hay ED. 2007. TGFbeta3 inhibits E-cadherin gene expression in palate medial-edge epithelial cells through a Smad2-Smad4-LEF1 transcription complex. J Cell Sci 120: 1646-1653.
26. Peng B, Fleming JB, Breslin T, Grau AM, Fojioka S, Abbruzzese JL, Evans DB, Ayers D, Wathen K, Wu T, Robertson KD, Chiao PJ. 2002. Suppression of Tumorigenesis and Induction of p15ink4b by Smad4/DPC4 in Human Pancreatic Cancer Cells. Clin Cancer Res 8: 3628-3638.
27. Pietenpol JA, Stein RW, Moran E, Yaciuk P, Schlegel R, Lyons RM, Pittelkow MR, Munger K, Howley PM, Moses HL. 1990. TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61: 777-785.
28. Sakaguchi M, Miyazaki M, Sonegawa H, Kashiwagi M, Ohba M, Kuroki T, Namba M, Huh NH. 2004. PKCalpha mediates TGFbeta-induced growth inhibition of human keratinocytes via phosphorylation of S100C/A11. J Cell Biol 164: 979-984.
29. Sanchez A, Alvarez AM, Lopez Pedrosa JM, Roncero C, Benito M, Fabregat I. 1999. Apoptotic response to TGF-beta in fetal hepatocytes depends upon their state of differentiation. Exp Cell Res 252: 281-291.
30. Satterwhite DJ, Moses HL. 1994. Mechanisms of transforming growth factor-beta 1-induced cell cycle arrest. Invasion Metastasis 14: 309-318.
31. Schutte BC, Murray JC. 1999. The many faces and factors of orofacial clefts. Hum Mol Genet 8: 1853-1859.
32. Seoane J, Pouponnot C, Staller P, Schader M, Eilers M, Massague J. 2001. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat Cell Biol 3: 400-408.
33. Thillainadesan G, Isovic M, Loney E, Andrews J, Tini M, Torchia J. 2008. Genome analysis identifies the p15ink4b tumor suppressor as a direct target of the ZNF217/CoREST complex. Mol Cell Biol 28: 6066-6077.
34. Tian M, Schiemann WP. 2009. The TGF-beta paradox in human cancer: an update. Future Oncol 5: 259-271.
35. Tian HY, Zhang KH, Gao X, Lei WW, Zhang L, Yu ML, Song JG, Zhao FK. 2009. Comparative proteomic analysis of cell cycle-dependent apoptosis induced by transforming growth factor-beta. Biochim Biophys Acta 1794: 1387-1397.
36. Tremain R, Marko M, Kinnimulki V, Ueno H, Bottinger E, Glick A. 2000. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras. Oncogene 19: 1698-1709.
37. Valdes F, Alvarez AM, Locascio A, Vega S, Herrera B, Fernandez M, Benito M, Nieto MA, Fabregat I. 2002. The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes. Mol Cancer Res 1: 68-78.
38. Vega S, Morales AV, Ocana OH, Valdes F, Fabregat I, Nieto MA. 2004. Snail blocks the cell cycle and confers resistance to cell death. Genes Dev 18: 1131-1143.
39. Wolff L, Garin MT, Koller R, Bies J, Liao W, Malumbres M, Tessarollo L, Powell D, Perella C. 2003. Hypermethylation of the Ink4b locus in murine myeloid leukemia and increased susceptibility to leukemia in p15(Ink4b)-deficient mice. Oncogene 22: 9265-9274.
40. Yang LT, Kaartinen V. 2007. Tgfb1 expressed in the Tgfb3 locus partially rescues the cleft palate phenotype of Tgfb3 null mutants. Dev Biol 312: 384-395.
41. Yang Y, Pan X, Lei W, Wang J, Shi J, Li F, Song J. 2006a. Regulation of transforming growth factor-{beta}1-induced apoptosis and epithelial-to-mesenchymal transition by protein kinase A and signal transducers and activators of transcription 3. Cancer Res 66: 8617-8624.
42. Yang Y, Pan X, Lei W, Wang J, Song J. 2006b. Transforming growth factor-beta1 induces epithelial-to-mesenchymal transition and apoptosis via a cell cycle-dependent mechanism. Oncogene 25: 7235-7244.